Explore more publications!

Healthcare Today Michigan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.

Press releases published on December 15, 2025

Kyverna Therapeutics Announces Positive Topline Data from Registrational KYSA-8 Trial of Miv-cel (KYV-101) in Stiff Person Syndrome
Palvella Therapeutics Announces Positive Topline Results from Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations, a Serious, Rare Genetic Disease with No…
Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01
NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
NANOBIOTIX va intégrer les indices CAC Mid 60 et SBF 120 d’Euronext Paris
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI
Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Communiqué de presse : Sanofi fait le point sur le tolébrutinib dans la sclérose en plaques primaire progressive
La protonthérapie, nouvelle norme de soins pour les patients atteints d'un cancer de l'oropharynx
Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Proton Therapy New Standard of Care for Patients with Oropharyngeal Cancer
Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolébrutinib dans la sclérose en plaques secondaire progressive non-récurrente
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
Byron Medical Announces the Product Release of BlancOne: a Science-Powered Breakthrough Redefining In-Chair Whitening Technology

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions